Viva Biotech Holdings (VB0) — Cash Flow Reinvestment Rate
Viva Biotech Holdings (VB0) has a Cash Flow Reinvestment Rate of 0.37x as of June 2023, reinvesting €57.96 Million (capex €50.80 Million plus investments €7.15 Million) from operating cash flow of €158.72 Million. Explore VB0 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Viva Biotech Holdings Cash Flow Reinvestment Rate (2016–2024)
Historical reinvestment intensity for Viva Biotech Holdings across 9 annual periods. Also explore VB0 asset base for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Viva Biotech Holdings (2016–2024)
Year-by-year capital reinvestment analysis for Viva Biotech Holdings. For live market cap and broader valuation context, see market value of Viva Biotech Holdings.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.91x | €340.66 Million | €373.99 Million | €191.67 Million | ▲ +45.0% |
| 2023 | 0.63x | €240.78 Million | €383.40 Million | €187.84 Million | ▼ -18.5% |
| 2022 | 0.77x | €297.35 Million | €386.05 Million | €249.33 Million | ▼ -91.7% |
| 2021 | 9.31x | €724.23 Million | €77.83 Million | €565.18 Million | ▼ -44.0% |
| 2020 | 16.61x | €717.04 Million | €43.18 Million | €592.62 Million | ▲ +219.8% |
| 2019 | 5.19x | €238.95 Million | €46.01 Million | €56.19 Million | ▼ -14.4% |
| 2018 | 6.07x | €73.46 Million | €12.11 Million | €46.90 Million | ▲ +484.9% |
| 2017 | 1.04x | €28.92 Million | €27.89 Million | €18.92 Million | ▼ -18.7% |
| 2016 | 1.28x | €26.93 Million | €21.12 Million | €7.34 Million | — |